These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18332609)

  • 21. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Torcetrapib/atorvastatin combination therapy.
    Bays H; McKenney J; Davidson M
    Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):789-820. PubMed ID: 16181026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
    Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertens Res; 2008 Jun; 31(6):1199-208. PubMed ID: 18716369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
    Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
    J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin.
    de Haan W; de Vries-van der Weij J; van der Hoorn JW; Gautier T; van der Hoogt CC; Westerterp M; Romijn JA; Jukema JW; Havekes LM; Princen HM; Rensen PC
    Circulation; 2008 May; 117(19):2515-22. PubMed ID: 18458167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.
    Lima JA; Desai MY; Steen H; Warren WP; Gautam S; Lai S
    Circulation; 2004 Oct; 110(16):2336-41. PubMed ID: 15477398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome with early aortic atherosclerosis in a child.
    Das S; Zhang S; Mitchell D; Gidding SS
    J Cardiometab Syndr; 2006; 1(4):286-7. PubMed ID: 17679800
    [No Abstract]   [Full Text] [Related]  

  • 29. Aortic plaque regression as determined by magnetic resonance imaging with high-dose and low-dose statin therapy.
    Gottlieb I; Agarwal S; Gautam S; Desai M; Steen H; Warren WP; Xavier SS; Lima JA
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):700-6. PubMed ID: 18545070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits.
    Oubiña MP; de las Heras N; Cediel E; Sanz-Rosa D; Aragoncillo P; Díaz C; Hernández G; Lahera V; Cachofeiro V
    Clin Sci (Lond); 2003 Dec; 105(6):655-62. PubMed ID: 12848617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.
    Junquero D; Bruniquel F; N'Guyen X; Autin JM; Patoiseau JF; Degryse AD; Colpaert FC; Delhon A
    Atherosclerosis; 2001 Mar; 155(1):131-42. PubMed ID: 11223434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit model.
    Alfon J; Pueyo Palazon C; Royo T; Badimon L
    Thromb Haemost; 1999 May; 81(5):822-7. PubMed ID: 10365759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
    Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ
    J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
    Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
    Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EP2306 [2-(4-biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbit.
    Tavridou A; Kaklamanis L; Papalois A; Kourounakis AP; Rekka EA; Kourounakis PN; Charalambous A; Manolopoulos VG
    J Pharmacol Exp Ther; 2007 Dec; 323(3):794-804. PubMed ID: 17804677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Zheng X; Cui XX; Avila GE; Huang MT; Liu Y; Patel J; Kong AN; Paulino R; Shih WJ; Lin Y; Rabson AB; Reddy BS; Conney AH
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5480-7. PubMed ID: 17875778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasa vasorum and plaque progression, and responses to atorvastatin in a rabbit model of atherosclerosis: contrast-enhanced ultrasound imaging and intravascular ultrasound study.
    Tian J; Hu S; Sun Y; Yu H; Han X; Cheng W; Ban X; Zhang S; Yu B; Jang IK
    Heart; 2013 Jan; 99(1):48-54. PubMed ID: 23100286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
    Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I
    Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.
    Gocmen AY; Ocak GA; Ozbilim G; Delibas N; Gumuslu S
    Can J Physiol Pharmacol; 2013 Sep; 91(9):680-5. PubMed ID: 23984971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.